Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants
Abstract Background Infants born extremely preterm are at high risk of dying or suffering from severe brain injuries. Treatment guided by monitoring of cerebral oxygenation may reduce the risk of death and neurologic complications. The SafeBoosC III trial evaluates the effects of treatment guided by...
Main Authors: | Mathias Lühr Hansen, Adelina Pellicer, Christian Gluud, Eugene Dempsey, Jonathan Mintzer, Simon Hyttel-Sorensen, Anne Marie Heuchan, Cornelia Hagmann, Gabriel Dimitriou, Gerhard Pichler, Gunnar Naulaers, Guoqiang Cheng, Ana Vilan, Jakub Tkaczyk, Karen B. Kreutzer, Monica Fumagalli, Olivier Claris, Siv Fredly, Tomasz Szczapa, Theis Lange, Janus Christian Jakobsen, Gorm Greisen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-019-3756-y |
Similar Items
-
The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial
by: Maria Linander Vestager, et al.
Published: (2023-10-01) -
Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial
by: Marie Isabel Rasmussen, et al.
Published: (2023-10-01) -
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.
by: Anne M Plomgaard, et al.
Published: (2017-01-01) -
Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach
by: Markus Harboe Olsen, et al.
Published: (2021-07-01) -
Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial
by: Anne Mette Plomgaard, et al.
Published: (2022-01-01)